ContentsIssue 107 • June 2021In association withRewriting the supply chain for a post-pandemic worldCovid-19 highlighted weak points in the pharma supply chain, but how can this be avoided in the future?IN DEPTHCreating an oral Covid-19 vaccineCommentMarketing oncology drugs in AsiaBriefingIndustry newsPharma industry briefingCovid-19 briefingCommentNew Chinese Breakthrough Therapy designation attracts foreign companiesNovel advancements for endometrial cancer patients Marketing an oncology drug in AsiaThe biopharma revolutionIn DepthDeveloping an oral Covid-19 vaccineImproving care for rare diseases in IndiaWhat’s in a drug name?Focus on the patient, not the pillAcademic-industry collaborationRewriting the pharma supply chainIn DataInside the dealDeals analysisMarket data02/24/2024 02:03:10
Comment
Marketing oncology drugs in Asia